footandanklefixation.blogspot.com
The Daily Fix: May 2011
http://footandanklefixation.blogspot.com/2011_05_01_archive.html
Saturday, May 21, 2011. 1st MPJ Arthrodesis with Locking Plate Debate. Check out this debate / point-counterpoint discussion on the necessity of using a locking plate or not when performing a 1st MPJ arthrodesis. Found in Podiatry Today's upcoming June issue, the discussion is held between Dr. Patrick Deheer, DPM, FACFAS and Dr. Shannnon Rush, DPM FACFAS. On the 1st MPJ arthrodesis page. Posted by Foot and Ankle Fixation. Labels: 1st MPJ Arthrodesis. Wednesday, May 18, 2011. New Ascension Mini Cal Plate.
bioworldperspectives.com
BioWorld Insight IndexChoose an Issue | BioWorld
http://bioworldperspectives.com/bioworld/insight/archive
Login to Your Account. BioWorld’s Partners in Focus. Start a risk-free subscription. January 04, 2016. January 11, 2016. January 19, 2016. January 25, 2016. February 01, 2016. February 08, 2016. February 16, 2016. February 22, 2016. February 29, 2016. March 07, 2016. March 14, 2016. March 21, 2016. March 28, 2016. April 04, 2016. April 11, 2016. April 18, 2016. April 25, 2016. May 02, 2016. May 09, 2016. May 16, 2016. May 23, 2016. May 31, 2016. June 06, 2016. June 13, 2016. June 20, 2016. June 27, 2016.
bioworldperspectives.com
BioWorld Asia (formerly International) IndexChoose an Issue | BioWorld
http://bioworldperspectives.com/bioworld/international/archive
Login to Your Account. BioWorld’s Partners in Focus. Start a risk-free subscription. BioWorld Asia (formerly International) Index. January 06, 2016. January 13, 2016. January 20, 2016. January 27, 2016. February 03, 2016. February 17, 2016. February 24, 2016. March 02, 2016. March 09, 2016. March 16, 2016. March 23, 2016. March 30, 2016. April 06, 2016. April 13, 2016. April 20, 2016. April 27, 2016. May 04, 2016. May 11, 2016. May 18, 2016. May 25, 2016. June 01, 2016. June 08, 2016. June 15, 2016.
bioworld.org
BioWorld | The Daily Biopharmaceutical News Source
http://www.bioworld.org/store-home
Login to Your Account. BioWorld’s Partners in Focus. Start a risk-free subscription. Biotech Reports See all. Biosimilars: A Global Perspective of a New Market Opportunities, Threats and Critical Strategies 2014. BioWorld's Executive Compensation Report 2014. BioWorld Biotechnology State of the Industry Report 2013. Biopharmaceutical Royalty Rates Analysis:Essential Benchmarks for Dealmaking. Medical Device Daily State of the Industry Report 2013: Insights and Innovations from Industry Leaders.
bioworldperspectives.com
BioWorld Today Archives IndexChoose an Issue | BioWorld
http://bioworldperspectives.com/bioworld/today/archive
Login to Your Account. BioWorld’s Partners in Focus. Start a risk-free subscription. BioWorld Today Archives Index. BioWorld’s Partners in Focus. BioWorld’s Partners in Focus. Our address has changed:. BioWorld 115 Perimeter Center Place. Suite: 1100 Atlanta, Georgia 30346, USA. For Sales Inquiries,. Http:/ ip-science.interest.thomsonreuters.com/Bioworld Sales Inquiry. Outside of the US. Part of Thomson Reuters. Note: our contact information has changed. In the U.S. and Canada: 1-800-336-4474.
bioworldperspectives.com
Achillion, Janssen HCV deal worth up to $1.1B; J&J investing $225M in separate transaction | BioWorld
http://bioworldperspectives.com/content/achillion-janssen-hcv-deal-worth-11b-jj-investing-225m-separate-transaction-0
Login to Your Account. BioWorld’s Partners in Focus. Start a risk-free subscription. Achillion, Janssen HCV deal worth up to $1.1B; J&J investing $225M in separate transaction. By Randy Osborne, Staff Writer. The company’s stock (NASDAQ:ACHN) was selling Tuesday in after-hours trading at $10.27, down 50 cents. Under the terms, Achillion is granting Janssen an exclusive, worldwide license to develop and, if approved, commercialize HCV products and regimens containing one or more of Achillion's assets in t...
bioworld.com
Cytokinetics advances its ALS candidate into phase III trial | BioWorld
http://www.bioworld.com/content/cytokinetics-advances-its-als-candidate-phase-iii-trial-0
Login to Your Account. Sorry, Sanofi: Pfizer plunks down $14B (say what? To take over Medivation. BioWorld’s Partners in Focus. Start a risk-free subscription. Cytokinetics advances its ALS candidate into phase III trial. Following a midstage trial showing its fast skeletal muscle activator, tirasemtiv. Delivered respiratory and muscular benefits to patients with amyotrophic lateral sclerosis (ALS) despite missing its primary endpoint, Cytokinetics. April 28, 2014.). Feb 17, 2015.). Secondary endpoints w...
bioworld.com
BioWorld | The Daily Biopharmaceutical News Source
http://www.bioworld.com/view/archives
Login to Your Account. BioWorld’s Partners in Focus. Start a risk-free subscription. Bioworld Today Archives Index. Bioworld International Archives Index. Bioworld Insight Archives Index. BioWorld’s Partners in Focus. BioWorld’s Partners in Focus. Our address has changed:. BioWorld 115 Perimeter Center Place. Suite: 1100 Atlanta, Georgia 30346, USA. For Sales Inquiries,. Http:/ ip-science.interest.thomsonreuters.com/Bioworld Sales Inquiry. Outside of the US. Part of Thomson Reuters.
SOCIAL ENGAGEMENT